📉 Nikkei is down nearly 5% -> here are 43 recession-proof Japanese stocks from our screenerUnlock Now

Creso Pharma has eyes on multi-million dollar functional mushroom product market

Published 10/05/2023, 12:40 pm
Updated 10/05/2023, 01:00 pm
© Reuters.  Creso Pharma has eyes on multi-million dollar functional mushroom product market

Creso Pharma Ltd (ASX:CPH, OTCQB:COPHF) will soon have a slice of the multi-million dollar global functional mushroom market with the launch of a new non-psychedelic product range by its US subsidiary Sierra Sage Herbs LLC (SSH).

The Lucenex functional mushroom products will give the company access to a market valued at US$26.7 million in 2021 and which is expected to grow at a compound annual growth rate (CAGR) of 10.8% between 2022 and 2030.

Additionally, SSH has expanded its distribution partnership with global e-commerce marketplace Groupon to scale the business in the US, Canada and into international markets.

Formulated in collaboration with Creso Pharma’s wholly-owned psychedelics subsidiary, Halucenex Life Sciences Inc, the new products will be sold through a soon-to-be launched in-house e-commerce site, www.lucenex.com, and via Amazon (NASDAQ:AMZN) USA.

SSH will also leverage its large retail footprint to drive sales through the traditional bricks and mortar business.

"Natural solution"

Creso chief executive officer and managing director William Lay said: “The expected launch of the company’s functional mushroom products follows considerable R&D and collaboration with Halucenex Life Sciences, in an effort to showcase our CPG product development knowledge and go-to market capabilities.

“We are very confident that the finished product will deliver another natural solution that will resonate with consumers and drive additional sales growth.

“Further, the expansion of the company’s agreement with Groupon reflects the ongoing strength of the working relationship with one of our key strategic distribution partners.

“The inclusion of additional SSH products marks another step in the company’s strategy to convert its existing market position into additional distribution opportunities.

“We look forward to providing more updates on SSH’s expansion strategy across the US market, both for its core brand suite as well as cross-selling opportunities for other Creso Pharma subsidiaries.”

Growing distribution footprint

SSH is hoping to reach a significantly larger audience through Groupon’s 22 million active customers.

The full range of 22 products from the Good Goo and Southern Butter brands will now be available through the American global e-commerce marketplace, which facilitated US$1.8 billion worth of transactions in 2022.

Read more on Proactive Investors AU

Disclaimer

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.